Skip to content

Medical-device intelligence

Bestgen Biotech Corp.: FDA clearances and recalls

Research Bestgen Biotech Corp. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

6 clearance records and 0 recall records in the covered releases, across 1 source company names and 2 product codes. Dated history runs from Feb 29, 2008 to Apr 24, 2012.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

6 matching records
Device / recordCompany in FDA recordSourceSource date
AP-3000 BLOOD GLUCOSE MONITORING SYSTEM, MAJOR GLUCOSE CONTROL SOLUTIONK103230 · CGABestgen Biotech Corp.510(k)Apr 24, 2012FDA decision date
AP-2000, AP-2010, AND AP-2020 BLOOD GLUCOSE MONITORING SYSTEMK103116 · CGABestgen Biotech Corp.510(k)Mar 13, 2012FDA decision date
AP-1010 AND AP-1020 BLOOD GLUCOSE MONITORING SYSTEM, MAJOR GLUCOSE CONTROL SOLUTIONK103044 · NBWBestgen Biotech Corp.510(k)Feb 10, 2012FDA decision date
AP-1000 BLOOD GLUCOSE MONITORING SYSTEM, MODEL AP-1000, MAJOR GLUCOSE CONTROL SOLUTIONK100437 · NBWBestgen Biotech Corp.510(k)Jan 12, 2012FDA decision date
AP-1000 BLOOD GLUCOSE MONITORING SYSTEMK090389 · NBWBestgen Biotech Corp.510(k)Jul 14, 2009FDA decision date
MAJOR III BLOOD GLUCOSE MONITORING SYSTEMK072274 · NBWBestgen Biotech Corp.510(k)Feb 29, 2008FDA decision date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗